Articles by Tyler Menichiello

  1. Reflecting On Continued Turbulence At The FDA 5/26/2026

    Bioprocess Online's Editorial Advisory Board responds to former FDA commissioner Marty Makary’s resignation amid a prolonged period of instability at the agency.

  2. Insufficient Vendor Data Is Hamstringing Single-Use Adoption 5/20/2026

    Audience polls and expert insights reveal insufficient vendor data as the main bottleneck stalling advanced single-use technology adoption. Explore that and other key takeaways in this recap of the Bioprocess Online Live event on "Closing The Adoption Gap For Advanced Single-Use Materials."

  3. On The Ground At NextGen Biomed 2026 4/29/2026

    Bioprocess Online caught up with Tiffany D. Rau, Ph.D., CMC consultant and adjunct professor of biochemistry and cell biology at the University College Cork in Ireland, at Oxford Global's 2026 NextGen Biomed conference.

  4. Integrate Upstream/Downstream To Reduce Development Risks And Costs 4/8/2026

    Coordinating unit operations can help reduce costs and mitigate challenges in process development. Check out these key takeaways from the Bioprocess Online Live event “Optimizing Process Development Through Upstream and Downstream Integration.”

  5. Taking The First Steps Towards Digitalizing Biopharma Development 1/28/2026

    AbbVie's head of biologics purification development and digitization teams, Moiz Diwan, Ph.D., and independent technology consultant Kat Kozyrytska share their thoughts on AI and smart technology adoption in this recap of the Bioprocess Online Live event, “How Digital Tools Are Accelerating Biopharma Development.” 

  6. Bioprocess Online's 2025 Editorial Reflections 12/23/2025

    Bioprocess Online's chief editor, Tyler Menichiello, reflects on the year and provides a preview of what to expect in 2026.

  7. FDA Releases Draft Guidance To Accelerate Biosimilar Development 10/31/2025

    New FDA draft guidance aims to reduce the timeline and cost of developing biosimilars.

  8. Supporting The Next Generation Of ADCs 10/30/2025

    Experts discuss innovation in antibody-drug conjugate (ADC) technology and how these impact CMC strategy. This summary captures key takeaways from the Bioprocess Online Live event "Evolving CMC Strategies To Enable Next-Gen ADCs."

  9. AbbVie And Amgen's Blueprint To Digitalize Biomanufacturing 10/10/2025

    At BioProcess International 2025, leaders from AbbVie and Amgen gave keynote presentations about how their companies are advancing product development through digital tools.

  10. On The Ground At BPI: Kat Kozyrytska On Ethical AI And Collaboration 9/29/2025

    AI consultant Kat Kozyrytska advocates for ethical AI adoption and explains its potential to foster collaboration across the industry.